News

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
Moderna stock is indeed in the doldrums today, but this offers the opportunity to buy at a reasonable price, and, 10 years ...
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...
Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...
The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...
The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.